To clarify that dysregulation of ANGPTL3 was a critical event in STAD, we performed further survival analysis on 273 high ANGPTL3 expressing STAD samples and 98 low expressing samples in the TCGA dataset. Here, ANGPTL3 is linked to gastric adenocarcinoma.